Analyst Downgrades – Galmed Pharmaceuticals (NASDAQ:GLMD) Stock Gets Downgraded By Maxim Group from Buy to Hold

Analyst Ratings For Galmed Pharmaceuticals (NASDAQ:GLMD)

Today, Galmed Pharmaceuticals (NASDAQ:GLMD) stock was downgraded by Maxim Group from Buy to Hold.

Some recent analyst ratings include

  • 2/14/2018-Maxim Group was Downgraded by analysts at Maxim Group from a “Buy ” rating to a ” Hold” rating.
  • 11/15/2017-Roth Capital initiated coverage with a Buy rating.
  • 10/6/2017-Seaport Global Securities Reiterated Rating of Buy.


    Recent Trading Activity for Galmed Pharmaceuticals (NASDAQ:GLMD)
    Shares of Galmed Pharmaceuticals closed the previous trading session at 4.20 down -5.26 55.60% with 4.385000228881836 shares trading hands.

    An ad to help with our costs